Related Experiment Video
Updated: Mar 15, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants
Artur Gieldon1, Dorota Zurawa-Janicka2, Miroslaw Jarzab2
1Faculty of Chemistry, University of Gdansk, Wita Stwosza 63, 80-308, Gdansk, Poland.
Abstract:
HtrA2(Omi) protease controls protein quality in mitochondria and plays a major role in apoptosis. Its HtrA2S306A mutant (with the catalytic serine routinely disabled for an X-ray study to avoid self-degradation) is a homotrimer whose subunits contain the serine protease domain (PD) and the regulatory PDZ domain. In the inactive state, a tight interdomain interface limits penetration of both PDZ-activating ligands and PD substrates into their respective target sites. We successfully crystalized HtrA2V226K/S306A, whose active counterpart HtrA2V226K has had higher proteolytic activity, suggesting higher propensity to opening the PD-PDZ interface than that of the wild type HtrA2. Yet, the crystal structure revealed the HtrA2V226K/S306A architecture typical of the inactive protein. To get a consistent interpretation of crystallographic data in the light of kinetic results, we employed molecular dynamics (MD). V325D inactivating mutant was used as a reference. Our simulations demonstrated that upon binding of a specific peptide ligand NH2-GWTMFWV-COOH, the PDZ domains open more dynamically in the wild type protease compared to the V226K mutant, whereas the movement is not observed in the V325D mutant. The movement relies on a PDZ vs. PD rotation which opens the PD-PDZ interface in a lid-like (budding flower-like in trimer) fashion. The noncovalent hinges A and B are provided by two clusters of interfacing residues, harboring V325D and V226K in the C- and N-terminal PD barrels, respectively. The opening of the subunit interfaces progresses in a sequential manner during the 50 ns MD simulation. In the systems without the ligand only minor PDZ shifts relative to PD are observed, but the interface does not open. Further activation-associated events, e.g. PDZ-L3 positional swap seen in any active HtrA protein (vs. HtrA2), were not observed. In summary, this study provides hints on the mechanism of activation of wtHtrA2, the dynamics of the inactive HtrA2V325D, but does not allow to explain an increased activity of HtrA2V226K.
Insights
The HtrA2 protease
Area of Science:
- Mitochondrial protein quality control
- Apoptosis regulation
- Enzyme kinetics and structural dynamics
Background:
- HtrA2 (Omi) protease is crucial for mitochondrial protein homeostasis and apoptosis.
- Its inactive state features a closed interdomain interface, limiting substrate access.
- Mutants like HtrA2S306A are used for structural studies, while V226K is known for higher activity.
Purpose of the Study:
- To investigate the activation mechanism of HtrA2 protease.
- To understand the structural dynamics of inactive and active HtrA2 mutants.
- To reconcile crystallographic data with kinetic observations using molecular dynamics.
Main Methods:
- X-ray crystallography of HtrA2V226K/S306A mutant.
- Molecular dynamics (MD) simulations of wild-type and mutant HtrA2 proteases.
- Analysis of interdomain interface dynamics upon ligand binding.
Main Results:
- Simulations revealed dynamic opening of PDZ domains in wild-type HtrA2 upon peptide ligand binding.
- This opening, a PDZ vs. PD rotation, sequentially unlocks the interdomain interface.
- The V226K mutant showed less dynamic opening than wild-type, and the V325D mutant remained largely inactive.
- Ligand-free systems exhibited minimal domain movement, and key activation events were not observed.
Conclusions:
- The study provides insights into the activation mechanism of wild-type HtrA2.
- It elucidates the dynamics of the inactive HtrA2V325D mutant.
- The increased activity of the HtrA2V226K mutant remains unexplained by the observed dynamics.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

